Professional
Added to YB: 2024-11-14
Pitch date: 2024-11-13
TXG [neutral]
10x Genomics, Inc.
+3.55%
current return
Author Info
Pernas Research is a former CIO of a $3.5B fund that now share actionable stock research. Sign up for the newsletter.
Company Info
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific.
Market Cap
$2.0B
Pitch Price
$14.93
Price Target
N/A
Dividend
N/A
EV/EBITDA
-18.65
P/E
-25.69
EV/Sales
2.52
Sector
Life Sciences Tools and Services
Category
value
Pernas Research Passes On: 10x Genomics, Inc.
TXG pass: Leader in single-cell analysis (75-80% mkt share) w/ Chromium platform. High throughput, cost-effective. Concerns: single product reliance, market saturation, slowing growth. P/S 4x, cash burn. $1.9B mrkt cap, $15.68 price.
Read full article (1 min)